Sanofi-Aventis To Ship 55.4 Mil. Fluzone Doses For 2004-05 Flu Season
This article was originally published in The Pink Sheet Daily
Executive Summary
The Centers for Disease Control & Prevention is requesting that the influenza vaccine go to "high-risk" individuals. FDA scientists will tour Chiron's Liverpool manufacturing facility Oct. 9-10 following the U.K.'s decision to suspend the release of Fluvirin for three months.
You may also be interested in...
Flu Vaccine Allotment Plan Prioritizes States With Chiron Contracts
All states should receive at least half of their contracted influenza vaccine supply in the first phase of Sanofi-Aventis’ Fluzone dose distribution in cooperation with the CDC. Other “first phase” recipients will include the Vaccines for Children program, pediatricians with Aventis contracts.
Flu Vaccine Allotment Plan Prioritizes States With Chiron Contracts
All states should receive at least half of their contracted influenza vaccine supply in the first phase of Sanofi-Aventis’ Fluzone dose distribution in cooperation with the CDC. Other “first phase” recipients will include the Vaccines for Children program, pediatricians with Aventis contracts.
Flu Vaccine Manufacturers Look To Government To Increase Demand
Aventis, MedImmune believe that expanding the recommended population for influenza vaccine will drive demand and spur additional manufacturers to enter the market, companies tell Government Reform Committee hearing.